Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | -9.52% | -31.81% | 0.00% |
22/04 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
22/04 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 15Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- BOLD Stock
- News Boundless Bio, Inc.
- Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target